Thyroid carcinoma is the most common endocrine cancer in the world. Over the last years attention has been focused on the role of microRNAs (miRs), small non-coding RNAs molecules, in the tumoral thyroid cell biology, especially in the diagnosis and prognosis of the papillary histotype (PTC). In a recent study of the group, the expression of miRs from the DLK1-DIO3 genomic region has been shown to be decreased in PTC. Importantly, distinct members from this genomic region have already been described as tumor suppressor miRs in several types of cancer. The aim of the project herein was to identify, based on target prediction and gene enrichment analysis, candidate miRs with tumor suppressor potential and to generate DNA plasmid constructions. MiR-495-3p and miR-485-5p were identified as the candidates with the highest tumor suppressor potential role in PTC among more than 50 miRs from the DLK1-DIO3 region. The construction of expression systems containing the miRs was performed based in mollecular clonning methodology and will certainly contribute to further functional validation of the role of these miRs in PTC.
Introduction
The papillary thyroid carcinoma (PTC) is the most prevalent histotype of thyroid cancer, comprising more than 80% of the cases in the United States 1 . Recently, the influence of miRs, small RNA molecules that play an important role in post-transcriptional regulation, has been demonstrated in tumorigenesis in virtually all types of cancer. MiR regulatory role rely on its potential to target mRNAs for cleavage or translational repression, based on nucleotide complementarity 2 . In PTC, several miRs have been reported to present oncogenic or tumor suppressor roles, including members of the cluster of DLK1-DIO3 region 3 . Our group recently identified a global decrease in the expression of the miRs of the DLK1-DIO3 region in PTC but the influence of this event in this type of cancer lacks further elucidation 4 . The role of DLK1-DIO3 miR cluster in PTC is reinforced by studies regarding the Temple Syndrome that show that a total or partial deletion of this region results in higher chances of premature thyroid cancer development 5 . Systems of constitutive expression have been successfully used to demonstrate the influence of the modulation of a single miR in tumorigenesis and cancer progression. Therefore, we aimed to construct systems for constitutive expression of selected miRs of the referred cluster to posteriorly investigate the effects of its modulation in tumorigenesis and PTC progression.
Results and Discussion
The establishment of PTC cell lines that overexpress miRs in a constitutive way is essential to make it possible to observe the effects on the modulation of these molecules in long term and in vivo.
Using bioinformatic tools, we ranked the miRs of the DLK1-DIO3 genomic region according with its potential of interacting with cancer related targets. The analysis pointed hsa-miR-485 and hsa-miR-495 as the candidates with the highest score based on predicted interactions with potential targets (Image 1).
Using Genome Browser, the genomic regions flanking the selected candidate miRs were identified and Forward (Fw) and Reverse (Rev) oligonucleotides were designed for each gene. To assure correct orientation of the insert within plasmid, sites for HindIII and EcoRI restriction enzymes were included in Fw and Rev primers, respectively. The resulting PCR products were then double-digested and ligated with pZsYellow1-C1 and pAmCyan1-C1 plasmids. The generation of stable miR-485 and -495 -expressing models will be of great importance for further in vitro and in vivo functional investigation of these genes in PTC. 
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